PROTHENA CORP PUBLIC LTD CO Cash and Equivalents

Quick Answer

PROTHENA CORP PUBLIC LTD CO reported Cash and Equivalents of $307.53 million for fiscal year 2025.

PROTHENA CORP PUBLIC LTD CO Cash and Equivalents — Annual History

Fiscal Year Cash and Equivalents YoY Change
2025 $307.53M -34.8%
2024 $471.39M -23.8%
2023 $618.83M -12.9%
2022 $710.41M +22.7%
2021 $579.09M +96.1%
2020 $295.38M -21.4%
2019 $375.72M -12.1%
2018 $427.66M +2.4%
2017 $417.62M +7.9%
2016 $386.92M +4.4%
2015 $370.59M +26.2%
2014 $293.58M +66.2%
2013 $176.68M +41.5%
2012 $124.86M
2011 $0.00
2010 $0.00

Quarterly Cash and Equivalents

Quarter Ending Cash and Equivalents YoY QoQ
September 30, 2025 $330.84M -36.3% -10.9%
June 30, 2025 $371.44M -34.2% -11.1%
March 31, 2025 $417.94M -23.5% -11.3%
December 31, 2024 $471.39M -23.8% -9.2%
September 30, 2024 $519.26M -22.6% -8.0%
June 30, 2024 $564.12M -14.4% +3.2%
March 31, 2024 $546.51M -20.4% -11.7%
December 31, 2023 $618.83M -12.9% -7.8%
  • PROTHENA CORP PUBLIC LTD CO showed a decrease of -34.8% in Cash and Equivalents compared to the prior fiscal year.
  • The most recent figure is from PROTHENA CORP PUBLIC LTD CO’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 27, 2026.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.

Last verified:

Leave a Comment